SANTANDREA, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 1.188
NA - Nord America 1.024
EU - Europa 635
SA - Sud America 170
AF - Africa 59
OC - Oceania 11
Totale 3.087
Nazione #
US - Stati Uniti d'America 984
CN - Cina 430
SG - Singapore 281
IT - Italia 234
HK - Hong Kong 161
BR - Brasile 139
GB - Regno Unito 97
VN - Vietnam 74
RU - Federazione Russa 60
KR - Corea 57
DE - Germania 56
SE - Svezia 54
ID - Indonesia 35
EG - Egitto 32
IN - India 26
IR - Iran 23
FI - Finlandia 21
MX - Messico 20
NL - Olanda 19
PK - Pakistan 19
FR - Francia 18
IQ - Iraq 17
AR - Argentina 16
CA - Canada 16
PL - Polonia 15
LT - Lituania 13
ZA - Sudafrica 12
AU - Australia 11
BD - Bangladesh 11
TR - Turchia 10
PH - Filippine 9
EC - Ecuador 8
JP - Giappone 7
UA - Ucraina 7
AT - Austria 6
ES - Italia 6
IL - Israele 6
NG - Nigeria 6
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
MA - Marocco 4
MY - Malesia 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
AM - Armenia 3
IE - Irlanda 3
PA - Panama 3
BF - Burkina Faso 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.087
Città #
Santa Clara 269
Hefei 227
Ashburn 186
Singapore 179
Hong Kong 149
London 56
Beijing 46
Seoul 44
Los Angeles 38
Chandler 35
New York 35
Ho Chi Minh City 31
Milan 26
Jakarta 22
Cairo 21
Fairfield 21
Nyköping 20
Shanghai 20
Buffalo 19
Chicago 18
Kent 16
Munich 16
São Paulo 16
The Dalles 16
Moscow 15
Helsinki 14
Bologna 13
Warsaw 13
Rome 11
Johannesburg 10
Florence 9
Islamabad 9
Naples 9
Nuremberg 9
Brembate di Sopra 8
Denver 8
Wuhan 8
Cambridge 7
Guayaquil 7
Salt Lake City 7
Atlanta 6
Giza 6
Hanoi 6
Mexico City 6
Portsmouth 6
Redondo Beach 6
Rio de Janeiro 6
Tokyo 6
Amsterdam 5
Ann Arbor 5
Baghdad 5
Bagno a Ripoli 5
Bari 5
Boston 5
Brooklyn 5
Campi Bisenzio 5
Catania 5
Council Bluffs 5
Houston 5
Migliarino 5
Orem 5
San Diego 5
Seattle 5
Turku 5
Belgrade 4
Belo Horizonte 4
Bremen 4
Dallas 4
Dhaka 4
Düsseldorf 4
Lagos 4
Lauterbourg 4
Manchester 4
Modena 4
Montreal 4
Parma 4
Perth 4
Porto Alegre 4
Princeton 4
Round Rock 4
Rutigliano 4
Sha Tin Wai 4
Sofia 4
Songpa-gu 4
Stockholm 4
Sunderland 4
Ankara 3
Appignano 3
Austin 3
Belfast 3
Da Nang 3
Dublin 3
Elk Grove Village 3
Erbil 3
Genoa 3
Gujranwala 3
Gyeongju 3
Haiphong 3
Hyderabad 3
Istanbul 3
Totale 1.941
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 477
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 186
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 161
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 151
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 145
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 142
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 126
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 124
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 117
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 116
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 114
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 113
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 111
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 102
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 101
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 98
PRAME expression in cellular neurothekeoma: A study of 11 cases 97
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 92
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 91
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 90
Digital spatial profiling for pathologists 89
null 83
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 59
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 58
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 54
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 24
Totale 3.121
Categoria #
all - tutte 13.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202267 11 18 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.233 18 41 45 100 215 175 115 65 147 53 118 141
2025/20261.240 221 157 221 295 332 14 0 0 0 0 0 0
Totale 3.121